Case series / case reportindependent cross-checkabstract checked★ key study I-GRN-110 in-depth review
Most coeliac patients back on gluten have hidden gut damage
Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet.
Overview
Matysiak-Budnik T et al.. Gut 2007 · PMID 17303598 · DOI 10.1136/gut.2006.100511
Of 61 symptom-free adults back on a normal diet, 48 had villous atrophy and many had bone loss; 13 had no atrophy, but some of those relapsed later.
Does the study support the specific claim? Partly · Methodological quality: low
Plain-language summary
Study explained simply
- What did the researchers want to find out?
Check whether all coeliac patients need lifelong GFD.
- How was the study done?
Retrospective follow-up with biopsies.
- How many people, animals or samples were studied?
61 adults diagnosed as children.
- What was actually found?
About 20% latent; 79% silent damage.
- How large was the observed effect?
Osteopenia 70% vs 11%.
- What do the results mean in everyday life?
No symptoms does not mean no harm.
- What are the study's limitations?
Small, selected.
- What does it say about Elawady's specific claim?
Partly supports tolerance in a minority; overall contradicts symptom-guided reintroduction.
- Do the results apply to Germany and Europe?
High.
- What can explicitly not be concluded from this study?
Cannot identify in advance who will tolerate gluten.
Scientific in-depth review
1. Full reference
- Authors
- Matysiak-Budnik T et al.
- Journal
- Gut
- Year
- 2007
- Identifier
- PMID 17303598 DOI 10.1136/gut.2006.100511 · PMC2000276
- Verification
- verified – PubMed efetch 2026-10-26; Crossref works API 2026-10-26
- Retracted
- no
- Corrections
- none
- Extent checked
- abstract only
- Conflicts of interest and funding
Authors declared no competing interests.
2. Research question
Is a lifelong gluten-free diet necessary in all patients diagnosed with coeliac disease in childhood?
3. Study design and population
- Study design
- Case series / case report – Retrospective clinical follow-up study
- Population
Adults (18-65) diagnosed with coeliac disease in childhood who had resumed a normal diet and were symptom-free
- Country
not stated in abstract
- Period
not stated in abstract
- Sample size
61 patients (+7 controls on a gluten-free diet)
- Inclusion and exclusion criteria
Clinically silent on a normal diet after gluten challenge
4. Methods and endpoints
- Exposure / intervention
Long-term gluten intake
- Comparator
Patients without atrophy (latent) vs with atrophy (silent); controls on GFD
- Endpoints
Villous atrophy, bone mineral density, serology, IEL subsets
- Statistical methods
Group comparisons
5. Actual results
- Results
48/61 had villous atrophy despite no symptoms (silent); 13/61 had no atrophy (latent). Osteopenia/osteoporosis 1/9 (11%) latent vs 23/33 (70%) silent, p<0.001. Two latent patients later relapsed clinically and histologically.
- Absolute risks
not reported
- Authors' conclusion
Latency developed in about 20% of patients symptom-free after gluten reintroduction; it can be transient, so regular follow-up is mandatory; in silent patients the increased osteoporosis risk substantiates the need for a GFD.
6. Strengths
- Biopsy and bone density data
- Long follow-up
7. Weaknesses
- Retrospective, selected
- Small
- Reported p<0.001 vs recalculated Fisher exact p=0.0025 (stats/C-GRN-03)
8. Risk of bias
- Orienting tool
- ROBINS-E
- Type of assessment
- simplified assessment (abstract only)
- Full formal assessment
- no
- Overall risk of bias
- high
- Rationale
Selected referral population; incomplete bone density data (42 of 61).
9. Assessment of the statistical interpretation
Proportions; recalculated Fisher p 0.0025 (still significant).
10. Relevance to the specific claim
The best "supporting" evidence: a minority tolerate gluten without atrophy. But 79% of symptom-free patients had villous atrophy, and 70% of them had low bone density.
11. Independent contrary findings
12. Transferability to Germany and Europe
High.
13. Overall methodological judgement
Mixed: acknowledges latency in a minority but shows that absence of symptoms hides damage in most.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | low |
| Risk of bias | high |
| Precision of results | low |
| Directness | direct |
| Reproducibility | partly replicated |
| Consistency with the overall evidence | consistent |
| Regional transferability | high |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
Predictors of latency.
15. Linked fact checks
- In a joint live stream on Elawady's channel, a speaker (Elawady or his guest Dr. Tamer El-Baz; speaker turns cannot be identified) describes a coeliac patient on the system who reintroduced gluten-containing toast, and advises pausing it when symptoms appear and reintroducing it later. – Studies with mixed or unclear results